However, rather than leptin deficient, obese persons often have hyperleptinemia specified as “selective leptin resistance” associated with MetS, type 2 diabetes and cardiovascular disease (CVD) [13], [14]. This evidence concerns the gene LEP and cardiovascular disorder.